Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum

Sarbjit S Saini; Carsten Bindslev-Jensen; Marcus Maurer; Jean-Jacques Grob; Emel Bülbül Baskan; Mary S Bradley; Janice Canvin; Abdelkader Rahmaoui; Panayiotis Georgiou; Oral Alpan; Sheldon Spector; Karin Rosén

doi:10.1038/jid.2014.512

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum

Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Mary S Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Investigative Dermatology
Vol/bind	135
Udgave nummer	3
Sider (fra-til)	925
ISSN	0022-202X
DOI	https://doi.org/10.1038/jid.2014.512
Status	Udgivet - mar. 2015

Dokumenter og links

10.1038/jid.2014.512

Citationsformater

Saini, S. S., Bindslev-Jensen, C., Maurer, M., Grob, J.-J., Bülbül Baskan, E., Bradley, M. S., Canvin, J., Rahmaoui, A., Georgiou, P., Alpan, O., Spector, S., & Rosén, K. (2015). Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum. Journal of Investigative Dermatology, 135(3), 925. https://doi.org/10.1038/jid.2014.512

@article{ea35ce3ef3f94e1d92b9282cc56aa8fd,

title = "Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum",

author = "Saini, {Sarbjit S} and Carsten Bindslev-Jensen and Marcus Maurer and Jean-Jacques Grob and {B{\"u}lb{\"u}l Baskan}, Emel and Bradley, {Mary S} and Janice Canvin and Abdelkader Rahmaoui and Panayiotis Georgiou and Oral Alpan and Sheldon Spector and Karin Ros{\'e}n",

year = "2015",

month = mar,

doi = "10.1038/jid.2014.512",

language = "English",

volume = "135",

pages = "925",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Nature Publishing Group",

number = "3",

}

Saini, SS, Bindslev-Jensen, C, Maurer, M, Grob, J-J, Bülbül Baskan, E, Bradley, MS, Canvin, J, Rahmaoui, A, Georgiou, P, Alpan, O, Spector, S & Rosén, K 2015, 'Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum', Journal of Investigative Dermatology, bind 135, nr. 3, s. 925. https://doi.org/10.1038/jid.2014.512

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum. / Saini, Sarbjit S; Bindslev-Jensen, Carsten; Maurer, Marcus et al.
I: Journal of Investigative Dermatology, Bind 135, Nr. 3, 03.2015, s. 925.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

T2 - Corrigendum

AU - Saini, Sarbjit S

AU - Bindslev-Jensen, Carsten

AU - Maurer, Marcus

AU - Grob, Jean-Jacques

AU - Bülbül Baskan, Emel

AU - Bradley, Mary S

AU - Canvin, Janice

AU - Rahmaoui, Abdelkader

AU - Georgiou, Panayiotis

AU - Alpan, Oral

AU - Spector, Sheldon

AU - Rosén, Karin

PY - 2015/3

Y1 - 2015/3

U2 - 10.1038/jid.2014.512

DO - 10.1038/jid.2014.512

M3 - Comment/debate

C2 - 25501032

SN - 0022-202X

VL - 135

SP - 925

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 3

ER -